Tauriga Sciences Inc. Invited to Participate in the Upcoming Kroger “Merchandising Planogram and Sales Planning” Event

Rhea-AI Summary

Tauriga Sciences, Inc. (TAUG), a diversified Retail Life Sciences and Pharmaceutical Development Company based in New York, has been invited to the Kroger "Merchandising Planogram and Sales Planning" event on March 23, 2022. This participation highlights the company's strategy to strengthen relationships with major retailers. Additionally, Tauriga is optimistic about forthcoming Federal Cannabis Legislation and has reported over 1,150 E-Commerce orders in the current quarter, totaling 9,690 since 2019.

New York, NY, March 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Retail Life Sciences and Pharmaceutical Development Company, today announced that it has been invited to participate in the upcoming Kroger “Merchandising Planogram and Sales Planning” event. This event takes place on March 23, 2022 and is part of the Kroger Supplier Inclusion Development Series.  Kroger is the United States’ largest supermarket chain by revenue and the second-largest general retailer behind Walmart.

The Company is focused on continually building its relationships with Buyers from large retail companies with national footprints.  The Company believes that once Federal Cannabis Legislation (“Legalization Bill”) is signed into law, it can establish a strong and reliable revenue base with mainstream retailers.  The Company is hopeful that such Legislation will be introduced during the month of April 2022.

In other news, the Company continues to experience strong levels of growth and demand – with respect to its highest margin E-Commerce business segment.  So far this Quarter, the Company has received more than 1,150 individual E-Commerce orders.  The Company has now received a total of 9,690 individual E-Commerce orders (“transactions”), since the 2019 launch of that business segment. 

E-Commerce Website: 

 www.taurigum.com

Amazon.com Website: 

https://www.amazon.com/s?k=tauri-gum&crid=1WDI6A48F2GK3&sprefix=tauri-gum%2Caps%2C81&ref=nb_sb_noss_1

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant), (DELTA 8 THC Infused Tauri-Gum™ Flavor: Evergreen Mint), (Vitamin C + Zinc Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum™ Flavor: Golden Raspberry). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company announced that it had Converted its U.S. Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.

The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates two full time E-Commerce fulfillment centers: one located in Montgomery, Texas and the other in Brooklyn, New York.

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Chief Executive Officer

Mr. Seth M. Shaw

Email: sshaw@tauriga.com

cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram: @sethsms47

Twitter: @SethMShaw

Corp. Website:   www.tauriga.com

E-Commerce Website:  www.taurigum.com

FAQ

What is the significance of Tauriga's participation in the Kroger event on March 23, 2022?

Tauriga's participation in the Kroger event signifies its commitment to building relationships with major retailers, which could enhance its market presence.

How many e-commerce orders has Tauriga Sciences received in the current quarter?

Tauriga has received over 1,150 individual e-commerce orders in the current quarter.

What is the total number of e-commerce transactions Tauriga has completed since 2019?

Since its e-commerce launch in 2019, Tauriga has completed a total of 9,690 individual transactions.

What does Tauriga expect from Federal Cannabis Legislation?

Tauriga believes that upon the legalization of cannabis, it can establish a strong revenue base with mainstream retailers.

What type of products does Tauriga Sciences offer?

Tauriga offers various CBD and CBG infused products, including its primary product, Tauri-Gum.